ai3Bio launches from stealth, Matchpoint's big raise for new autoimmune drug, layoffs at Foghorn and Enanta
Plus another Eli Lilly acquisition moves to Arsenal Yards
Another Watertown Biotech Goes Public via Reverse Merger, and a Flurry of Leasing at the Arsenal
Plus Biolabs expansion and Labshare's new tenants